Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Poynard

Showing results (201-210 of 324) with videos related to

Pageof 33
Sort By:
Transplantation Proceedings|January 3, 2001
Chronic hepatitis B treatment with lamivudine in kidney transplant patientsC Mouquet, B Bernard, T Poynard, et al.
Annales De Biologie Clinique|August 3, 2005
[Alpha 2 macroglobulin immunoturbidimetric assays (DakoCytomation reagents) on Roche Diagnostic analysers (Modular P, Cobas Integra). Application to FibroTest-Actic-Test]A Piton, D Messous, F Imbert-Bismut, et al.
Journal of Viral Hepatitis|June 9, 2012
Evolution of biomarkers of liver fibrosis and liver insufficiency in hepatitis C virus-infected patients treated with pegylated interferon plus ribavirin and rituximabG Geri, B Terrier, F Imbert-Bismut, et al.
The New England Journal of Medicine|May 30, 1991
Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study GroupT Poynard, P Calès, L Pasta, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1996
[Prevalence of serum anti-hepatitis C virus antibodies and risk factors of contamination in the personnel of a hospital in the Paris region. A prospective survey]M F Maillard, T Poynard, P Dubreuil, et al.
Journal of Viral Hepatitis|March 28, 2008
FibroTest is effective in patients with normal transaminases, when accuracy is standardized on fibrosis stage prevalenceT Poynard, M Munteanu, Y Ngo, et al.
Alimentary Pharmacology & Therapeutics|March 6, 2002
Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysisC Goulenok, B Bernard, J F Cadranel, et al.
Presse Medicale (Paris, France : 1983)|November 17, 1984
[Peri-anal ulceration. Tuberculosis should not be overlooked]P C Le Bourgeois, T Poynard, J Modai, et al.
Gastroenterologie Clinique Et Biologique|September 4, 2009
Evaluation of FibroTest-ActiTest in children with chronic hepatitis C virus infectionB Hermeziu, D Messous, M Fabre, et al.
Journal of Viral Hepatitis|July 1, 1997
Effects of cirrhosis, interferon and azathioprine on adverse events in patients with chronic hepatitis C treated with ribavirinT Thevenot, P Mathurin, J Moussalli, et al.
Pageof 33

Showing results (201-210 of 324) with videos related to

Sort By:
Pageof 33
Transplantation Proceedings|January 3, 2001
Chronic hepatitis B treatment with lamivudine in kidney transplant patientsC Mouquet, B Bernard, T Poynard, et al.
Annales De Biologie Clinique|August 3, 2005
[Alpha 2 macroglobulin immunoturbidimetric assays (DakoCytomation reagents) on Roche Diagnostic analysers (Modular P, Cobas Integra). Application to FibroTest-Actic-Test]A Piton, D Messous, F Imbert-Bismut, et al.
Journal of Viral Hepatitis|June 9, 2012
Evolution of biomarkers of liver fibrosis and liver insufficiency in hepatitis C virus-infected patients treated with pegylated interferon plus ribavirin and rituximabG Geri, B Terrier, F Imbert-Bismut, et al.
The New England Journal of Medicine|May 30, 1991
Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study GroupT Poynard, P Calès, L Pasta, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1996
[Prevalence of serum anti-hepatitis C virus antibodies and risk factors of contamination in the personnel of a hospital in the Paris region. A prospective survey]M F Maillard, T Poynard, P Dubreuil, et al.
Journal of Viral Hepatitis|March 28, 2008
FibroTest is effective in patients with normal transaminases, when accuracy is standardized on fibrosis stage prevalenceT Poynard, M Munteanu, Y Ngo, et al.
Alimentary Pharmacology & Therapeutics|March 6, 2002
Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysisC Goulenok, B Bernard, J F Cadranel, et al.
Presse Medicale (Paris, France : 1983)|November 17, 1984
[Peri-anal ulceration. Tuberculosis should not be overlooked]P C Le Bourgeois, T Poynard, J Modai, et al.
Gastroenterologie Clinique Et Biologique|September 4, 2009
Evaluation of FibroTest-ActiTest in children with chronic hepatitis C virus infectionB Hermeziu, D Messous, M Fabre, et al.
Journal of Viral Hepatitis|July 1, 1997
Effects of cirrhosis, interferon and azathioprine on adverse events in patients with chronic hepatitis C treated with ribavirinT Thevenot, P Mathurin, J Moussalli, et al.
Pageof 33